Whanin Pharm seeking suit to confirm non-presence of liabilities over Merck-Lipha

Whanin Pharm said it is seeking a local court's ruling over the liabilities incurred out of an annulled secrecy agreement executed earlier with France-based Merck-Lipha, while

According to Whanin, the company had aimed to introduce acamprosate, a medication for alcohol abuse and alcoholism treatment, into Korea on April 1995 but after signature of secrecy agreement, Merck-Lipha's uncooperat...